Corporate News     12-Dec-18
Stides Vivimed gets USFDA approval for Albendazole Tablets
Vivimed Labs announced that its 50:50 JV Strides Vivimed, Singapore has received approval for Albendazole Tablets USP 200mg from the united States Food & Drug Administration (USFDA). This is the second generic approval by USFDA for Albendazole Tablets.

Albendazole Tablets is a generic version of Albenza Tablets@ of Amneal pharmaceuticals, Inc. According to IQVIA MAT data, the US market for Albendazole Tablets USP 200 mg is approximately US$ 100 Mn.

Previous News
  Vivimed Labs reports consolidated net loss of Rs 20.30 crore in the September 2023 quarter
 ( Results - Announcements 16-Nov-23   12:49 )
  Vivimed Labs reports consolidated net loss of Rs 22.20 crore in the June 2022 quarter
 ( Results - Announcements 13-Aug-22   08:15 )
  Vivimed Labs to hold board meeting
 ( Corporate News - 29-Jun-24   17:38 )
  Vivimed Labs consolidated net profit rises 26.50% in the June 2020 quarter
 ( Results - Announcements 31-Aug-20   08:18 )
  Vivimed Labs standalone net profit declines 21.47% in the June 2018 quarter
 ( Results - Announcements 14-Aug-18   12:42 )
  Vivimed Labs consolidated net profit rises 19.08% in the June 2018 quarter
 ( Results - Announcements 14-Aug-18   12:41 )
  Next Mediaworks Ltd leads losers in 'B' group
 ( Hot Pursuit - 11-Dec-19   14:45 )
  Vivimed Labs consolidated net profit rises 12.44% in the September 2016 quarter
 ( Results - Announcements 14-Nov-16   15:47 )
  Vivimed Labs standalone net profit declines 48.05% in the September 2015 quarter
 ( Results - Announcements 13-Nov-15   12:36 )
  Vivimed Labs Ltd Spurts 3.01%
 ( Hot Pursuit - 04-Jul-19   09:30 )
  Vivimed Labs consolidated net profit rises 45.52% in the September 2015 quarter
 ( Results - Announcements 13-Nov-15   12:37 )
Other Stories
  Share India Securities allots 16.92 lakh equity shares on conversion of warrants
  06-Jul-24   13:11
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
Back Top